12:00 AM
 | 
May 06, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Ipsen sales and marketing update

Ipsen said it expects a supply interruption of Increlex mecasermin in the U.S. this quarter and in Europe and the rest of the world next quarter due to undisclosed manufacturing...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >